Gelteq Limited (GELS) vs InMed Pharmaceuticals Inc. (INM)

Gelteq Limited and InMed Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. InMed Pharmaceuticals Inc. is the larger, with a market value of $7.7M against $5.9M — 1.3× the size. Across the 7 metrics below, Gelteq Limited leads on 4 and InMed Pharmaceuticals Inc. on 3.

Valuation

Metric GELS INM Drug Manufacturers Specialty & Generic median
P/E — n/m 20.14
P/S — 1.00 2.25
P/B n/m 5.35 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 0.65 2.56
Earnings yield — (218.43%) (2.99%)
Free cash flow yield 0.00% (151.13%) 0.00%

Profitability

Metric GELS INM Drug Manufacturers Specialty & Generic median
Gross margin — 26.27% 53.94%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (179.09%) (0.40%)
Return on assets 0.00% (139.63%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GELS INM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 19.38% 10.01%
EPS growth (last fiscal year) (62.07%) 62.68% —
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GELS INM Drug Manufacturers Specialty & Generic median
Debt to equity 0.36 0.00 0.05
Current ratio 0.09 1.37 2.31
Net debt to EBITDA (0.91) 0.20 0.85

Dividend

Metric GELS INM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric GELS INM Drug Manufacturers Specialty & Generic median
Market cap 5.89m 7.69m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack